Navigation Links
Fungitell(R) CE Marked, Referenced in IDSA and NCCN Guidelines and Added to EORTC-MSG Revised Definitions of Invasive Fungal Disease
Date:6/3/2008

EAST FALMOUTH, Mass., June 3 /PRNewswire/ -- Associates of Cape Cod, Inc. (ACC), a leading manufacturer of endotoxin and beta-glucan detection products, today announced that the Fungitell(R) assay kit, for the measurement of (1-->3)-beta-D-Glucan, a fungal cell wall component, has been CE marked, which enables distribution in the European Union (EU). In addition, this important assay has been included in both the Infectious Disease Society of America's (IDSA) Clinical Practice Guidelines for the treatment of Aspergillosis, and the National Comprehensive Cancer Network(R) (NCCN) 2008 Clinical Practice Guidelines in Oncology(TM), "Prevention and Treatment of Cancer-Related Infections." The IDSA guidelines are published in the February 1st edition of the Clinical Infectious Diseases 2008; 46:327-60, and can be viewed at http://www.journals.uchicago.edu/toc/cid/46/3. The NCCN guideline was published 1/16/08, and can be viewed at http://www.nccn.org/professionals/physician_gls/PDF/infections.pdf. The revised European Organization for Research and Treatment of Cancer-Mycosis Study Group (EORTC-MSG) definitions will be appearing in the June 15, 2008 edition of Clinical Infections Diseases (Univ. of Chicago Press).

Fungitell(R) measures (1-->3)-beta-D-Glucan in patient serum and is sensitive to as little as a few trillionths of a gram. The assay is used for patients at risk of fungal infection, including immuno-compromised patients, such as transplant recipients or those with cancer. The kit can be used in hospital laboratories or patient samples can be tested at ACC's Beacon Diagnostics(R) Laboratory.

Dr. AJ Meuse, President and CEO of ACC, stated, "The CE mark opens the door for distribution in all EU member states. Since the introduction of Fungitell(R), we have had numerous inquiries and requests for the product from Europe. The value of the Fungitell(R) assay is recognized by physicians in the EU and we can now provide them with this invaluable aid in the diagnosis of invasive fungal infections."

"The references to Fungitell(R) in the NCCN and IDSA's Guidelines are indicative of the increasing awareness of the potential benefit of early diagnosis of invasive fungal infections," said Dr. AJ Meuse. He further stated, "Early detection and treatment leads to better patient outcomes, shorter treatment regimens and may reduce the overall cost of treatment. Fungitell is an import aid to early diagnosis. The use of the Fungitell(R) assay has grown tremendously since its introduction in early 2005, and we are very optimistic that it will continue to be an integral part of the diagnosis and treatment of these critically ill patients. The EORTC-MSG definitions are looked to by the leading experts in mycotic diseases as key criteria for the standardization of diagnostic determinations of invasive fungal disease."

About Associates of Cape Cod, Inc.

Associates of Cape Cod, Inc., based in East Falmouth, MA, is a leader in the field of bacterial endotoxin and beta-glucan detection and a major supplier to the pharmaceutical, medical device and clinical diagnostic industries. A wholly owned subsidiary of Seikagaku BioBusiness Corporation, the Company pioneered the humane use of horseshoe crab blood extract, Limulus Amebocyte Lysate (LAL), used in the testing of pharmaceuticals, medical devices and biologics, for the presence of potentially toxic endotoxins and glucans. Our products are marketed throughout the world under the trade names Pyrotell(R), Glucatell(R), Pyrochrome(R) and Chromo-LAL. The Company offers contract testing for endotoxin and (1,3)-beta-D-glucan, and has a research biochemicals division, Northstar BioProducts(TM), specializing in carbohydrate chemistry. For more information about Associates of Cape Cod, Inc. and our products, please visit our websites at: http://www.acciusa.com and http://www.beacondiagnostics.com

Company Contact:

Debbie Fraser

508-540-3808, ext. 2228

press@acciusa.com


'/>"/>
SOURCE Associates of Cape Cod, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. American Urological Association (AUA) Clinical Guidelines Recognizes Cryotherapy as Treatment Option for Prostate Cancer Patients
2. Atherotech VAP Cholesterol Test Meets Updated ADA, ACC Measurement and Treatment Guidelines for High Risk Patients
3. Biopure Operations Compliant With U.K. Manufacturing Guidelines
4. Long-awaited international ethical guidelines for biobank researchers
5. Updated NIH Guidelines Offer Valuable Information on Asthma Diagnosis and Management
6. Reed Group to Provide MDA Internet Disability Duration Guidelines to U.S. Navy
7. Ranexa(R) Added to New ACC/AHA Guidelines on Unstable Angina/Non ST-Elevation Myocardial Infarction (UA/NSTEMI)
8. Biodel Inc. Added to NASDAQ Biotechnology Index
9. Eurand Added to NASDAQ Biotechnology Index
10. ev3 Inc. Reports 2008 First Quarter Financial Results and Revised 2008 Guidance
11. REVISED: BrainCells Inc. Expands Series B Financing to $50 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... Rolf K. Hoffmann, ... faculty of the University of North Carolina Kenan-Flagler Business School effective ... at UNC Kenan-Flagler, with a focus on the school’s international efforts, leading classes ...
(Date:6/24/2016)... June 24, 2016  Regular discussions on a range of ... between the two entities said Poloz. Speaking at ... Ottawa , he pointed to the country,s inflation target, ... government. "In certain ... institutions have common economic goals, why not sit down and ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica delle Marche in ... peritoneal or pleural mesothelioma. Their findings are the subject of a new article on ... biomarkers are signposts in the blood, lung fluid or tissue of mesothelioma patients that ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
Breaking Biology Technology:
(Date:5/20/2016)... 2016  VoiceIt is excited to announce its ... By working together, VoiceIt and VoicePass will ... VoicePass take slightly different approaches to voice biometrics, ... and usability. ... partnership. "This marketing and technology partnership ...
(Date:5/3/2016)... May 3, 2016  Neurotechnology, a provider of ... MegaMatcher Automated Biometric Identification System (ABIS) , a ... projects. MegaMatcher ABIS can process multiple complex biometric ... combination of fingerprint, face or iris biometrics. It ... and MegaMatcher Accelerator , which have ...
(Date:4/26/2016)... April 27, 2016 Research ... Multi-modal Biometrics Market 2016-2020"  report to their offering.  ... The analysts forecast the global multimodal ... 15.49% during the period 2016-2020.  Multimodal ... sectors such as the healthcare, BFSI, transportation, automotive, ...
Breaking Biology News(10 mins):